Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A kinetic model for 99mTc-DMSA in the rat.

D C Maneval1, D Z D'Argenio, W Wolf

  • 1Department of Biomedical Engineering, University of Southern California, Los Angeles 90089-1451.

European Journal of Nuclear Medicine
|January 1, 1990
PubMed
Summary

Unlabeled dimercaptosuccinic acid (DMSA) saturates kidney uptake of technetium-99m DMSA (99mTc-DMSA) in rats, increasing urinary elimination without altering urine clearance. This suggests dual renal handling mechanisms for 99mTc-DMSA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens.

Antimicrobial agents and chemotherapy·2020
Same author

Transient recovery from trypsin-caused reduction in fertilizability of sea urchin eggs.

Wilhelm Roux's archives of developmental biology·2017
Same author

Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C Virus.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Clinical pharmacology and therapeutics·2016
Same author

H in α-Zr and in zirconium hydrides: solubility, effect on dimensional changes, and the role of defects.

Journal of physics. Condensed matter : an Institute of Physics journal·2014
Same author

Endocrinology in medical practice.

The interne·2010

Area of Science:

  • Nuclear medicine
  • Pharmacokinetics
  • Renal physiology

Background:

  • Technetium-99m dimercaptosuccinic acid (99mTc-DMSA) is a key renal imaging agent.
  • Understanding its pharmacokinetic behavior is crucial for accurate diagnostic interpretation.

Purpose of the Study:

  • To develop a pharmacokinetic model for 99mTc-DMSA in rats.
  • To investigate the effect of unlabeled DMSA on 99mTc-DMSA disposition.

Main Methods:

  • Developed a pharmacokinetic model using serial blood, urine, and dynamic imaging data over 8 hours in anesthetized rats.
  • Administered 99mTc-DMSA alone or with a pre-dose of unlabeled DMSA (10 mg/kg).

Main Results:

  • Unlabeled DMSA significantly reduced kidney accumulation and increased urinary elimination of 99mTc.

Related Experiment Videos

  • Kidney clearance was significantly lower with unlabeled DMSA, but urine clearance estimates did not differ significantly.
  • Increased urinary elimination occurred without changes in urine clearance, suggesting saturation of kidney uptake mechanisms.

    • Conclusions:

    • The results support a model where renal handling of 99mTc-DMSA involves both glomerular filtration and peritubular capillary uptake.
    • Unlabeled DMSA appears to saturate the uptake mechanism without affecting urinary clearance.
    • Simultaneous data acquisition provides a comprehensive model of 99mTc-DMSA physiological disposition.